Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Micromet Inc (MITI) -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (44)	8/6/2006 12:23:24 PM
From: dr.praveen	Respond to of 196

Hi tuck, I kind of stopped following them actively till I see the P2 results coz they didn't reach the MTD yet and are still tinkering with the regimen. Their PR "continuous infusion of MT103 over a 4- to 8-week period at escalating dose levels?" is not very clear. How many hrs per day? How many days? Is it everyday or alt days or particular days per week? Coz of all these uncertainities, I want to revisit them after the p2 results. If they don't show more efficacy than Rituxan or dose adv, they won't get much in the market. Regards, Praveen